BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

159 related articles for article (PubMed ID: 10390423)

  • 1. Initial microbiologic studies did not affect outcome in adults hospitalized with community-acquired pneumonia.
    Sanyal S; Smith PR; Saha AC; Gupta S; Berkowitz L; Homel P
    Am J Respir Crit Care Med; 1999 Jul; 160(1):346-8. PubMed ID: 10390423
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Guideline-concordant antibiotic use and survival among patients with community-acquired pneumonia admitted to the intensive care unit.
    Frei CR; Attridge RT; Mortensen EM; Restrepo MI; Yu Y; Oramasionwu CU; Ruiz JL; Burgess DS
    Clin Ther; 2010 Feb; 32(2):293-9. PubMed ID: 20206787
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Outcomes of health care-associated pneumonia empirically treated with guideline-concordant regimens versus community-acquired pneumonia guideline-concordant regimens for patients admitted to acute care wards from home.
    Chen JI; Slater LN; Kurdgelashvili G; Husain KO; Gentry CA
    Ann Pharmacother; 2013 Jan; 47(1):9-19. PubMed ID: 23324506
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Does sputum culture affect the management and/or outcome of community-acquired pneumonia?
    Shariatzadeh MR; Marrie TJ
    East Mediterr Health J; 2009; 15(4):792-9. PubMed ID: 20187530
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The etiology of community-acquired pneumonia in Australia: why penicillin plus doxycycline or a macrolide is the most appropriate therapy.
    Charles PG; Whitby M; Fuller AJ; Stirling R; Wright AA; Korman TM; Holmes PW; Christiansen KJ; Waterer GW; Pierce RJ; Mayall BC; Armstrong JG; Catton MG; Nimmo GR; Johnson B; Hooy M; Grayson ML;
    Clin Infect Dis; 2008 May; 46(10):1513-21. PubMed ID: 18419484
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Impact of guideline-consistent therapy on outcome of patients with healthcare-associated and community-acquired pneumonia.
    Grenier C; Pépin J; Nault V; Howson J; Fournier X; Poirier MS; Cabana J; Craig C; Beaudoin M; Valiquette L
    J Antimicrob Chemother; 2011 Jul; 66(7):1617-24. PubMed ID: 21586592
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Medical outcomes and antimicrobial compliance according to the Chilean Society of Respiratory Diseases guidelines for hospitalized patients with community acquired pneumonia].
    Díaz A; Kuzmanic G; Platzer L; Sanfuentes F; Espinoza MA; Saldías F
    Rev Med Chil; 2003 Aug; 131(8):847-56. PubMed ID: 14558238
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Commentary on the 1993 American Thoracic Society guidelines for the treatment of community-acquired pneumonia.
    Campbell GD
    Chest; 1999 Mar; 115(3 Suppl):14S-18S. PubMed ID: 10084454
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Community acquired bacterial pneumonia.
    Anevlavis S; Bouros D
    Expert Opin Pharmacother; 2010 Feb; 11(3):361-74. PubMed ID: 20085502
    [TBL] [Abstract][Full Text] [Related]  

  • 10. A new strategy for healthcare-associated pneumonia: a 2-year prospective multicenter cohort study using risk factors for multidrug-resistant pathogens to select initial empiric therapy.
    Maruyama T; Fujisawa T; Okuno M; Toyoshima H; Tsutsui K; Maeda H; Yuda H; Yoshida M; Kobayashi H; Taguchi O; Gabazza EC; Takei Y; Miyashita N; Ihara T; Brito V; Niederman MS
    Clin Infect Dis; 2013 Nov; 57(10):1373-83. PubMed ID: 23999080
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Ceftaroline fosamil for treatment of community-acquired pneumonia: findings from FOCUS 1 and 2 and potential role in therapy.
    DiMondi VP; Drew RH; Chen LF
    Expert Rev Anti Infect Ther; 2011 Aug; 9(8):567-72. PubMed ID: 21819323
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Mortality differences among hospitalized patients with community-acquired pneumonia in three world regions: results from the Community-Acquired Pneumonia Organization (CAPO) International Cohort Study.
    Arnold FW; Wiemken TL; Peyrani P; Ramirez JA; Brock GN;
    Respir Med; 2013 Jul; 107(7):1101-11. PubMed ID: 23660396
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Azithromycin monotherapy for patients hospitalized with community-acquired pneumonia: a 31/2-year experience from a veterans affairs hospital.
    Feldman RB; Rhew DC; Wong JY; Charles RA; Goetz MB;
    Arch Intern Med; 2003 Jul; 163(14):1718-26. PubMed ID: 12885688
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Initial antibiotic management of community acquired pneumonia.
    Astin GT; Honig E; Shipp C; Moore B; McClellan W
    J Med Assoc Ga; 1997 Apr; 86(2):105-8. PubMed ID: 9114656
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Validation of the Infectious Diseases Society of America/American Thoracic Society criteria to predict severe community-acquired pneumonia caused by Streptococcus pneumoniae.
    Kontou P; Kuti JL; Nicolau DP
    Am J Emerg Med; 2009 Oct; 27(8):968-74. PubMed ID: 19857416
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Impact of infectious etiology on the outcome of Taiwanese patients hospitalized with community acquired pneumonia.
    Lee YT; Chen SC; Chan KC; Wu TC; Tsao SM; Chan CH
    J Infect Dev Ctries; 2013 Feb; 7(2):116-24. PubMed ID: 23416657
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The aetiology of community-acquired pneumonia and implications for patient management.
    van Gageldonk-Lafeber AB; Wever PC; van der Lubben IM; de Jager CP; Meijer A; de Vries MC; Elberse K; van der Sande MA; van der Hoek W
    Neth J Med; 2013 Oct; 71(8):418-25. PubMed ID: 24127502
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Role of 'atypical pathogens' among adult hospitalized patients with community-acquired pneumonia.
    Lui G; Ip M; Lee N; Rainer TH; Man SY; Cockram CS; Antonio GE; Ng MH; Chan MH; Chau SS; Mak P; Chan PK; Ahuja AT; Sung JJ; Hui DS
    Respirology; 2009 Nov; 14(8):1098-105. PubMed ID: 19818051
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Diagnosis and management of community-acquired pneumonia in adults.
    Watkins RR; Lemonovich TL
    Am Fam Physician; 2011 Jun; 83(11):1299-306. PubMed ID: 21661712
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Empiric treatment in hospitalized community-acquired pneumonia. Impact on mortality, length of stay and re-admission.
    Reyes Calzada S; Martínez Tomas R; Cremades Romero MJ; Martínez Moragón E; Soler Cataluña JJ; Menéndez Villanueva R
    Respir Med; 2007 Sep; 101(9):1909-15. PubMed ID: 17628462
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.